214
Participants
Start Date
September 30, 2007
Primary Completion Date
September 30, 2008
Study Completion Date
December 31, 2008
4975, 15 and 5 mg
Direct instillation into the surgical site
Placebo Comparator
Direct instillation into the surgical site
4975 - 5 mg
Direct instillation into the surgical site
Sewickley Valley Hospital, Sewickley
Temple University Hospital, Philadelphia
Ruxton Professional Center - Orthopaedic Associates, Towson
Coastal Medical Research, Port Orange
Florida Hospital - Florida Research Associates, LLC, DeLand
Southeastern Clinical Research Consultants, Orlando
University of Miami, Miller School of Medicine, Miami
Miami Institute for Medical Research, Miami
Alabama Clinical Therapeutics, LLC, Birmingham
Hellen Keller Hospital, Sheffield
Springhill Medical Center, Mobile
Cleveland Clinic, Cleveland
William Beaumont Hospital, Royal Oak
William Beaumont Hospital, Troy
Rush University Medical Center, Chicago
Presbyterian Hospital of Dallas, Dallas
Memorial City Hospital - Memorial Hermann Healthcare System, Houston
Visions Clinical Research/Tucson Medical Center, Tucson
Glendale Adventist Medical Center - Lotus Clinical Research, Glendale
Physicians Clinical Research Corporation, Laguna Hills
Saddleback Memorial Medical Center/Accurate Clinical Trials, Laguna Hills
UCSF-Mt. Zion Medical Center, San Francisco
Webster Orthopeadic Medical Group, Oakland
Oregon Health & Science University, Portland
Orthopedic Associates of Hartford, Hartford
Lead Sponsor
Anesiva, Inc.
INDUSTRY